U.S. FDA, Congress to Write CBD its Own Rules for Food, Supplements

After careful review, the U.S. Food and Drug Administration (FDA) has concluded that a regulatory pathway specific to CBD, rather than CBD foods and supplements, is needed to balance CBD product demand with the potential risks.

Related Keywords

Janet Woodcock ,Drug Administration ,Regulatory Line ,Cannabinoids Fit Into ,